| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/PHYSIOLGENOMICS.00122.2001 |
| P8608 | Fatcat ID | release_geivevvoa5agziwvb4vrllcdv4 |
| P698 | PubMed publication ID | 12118103 |
| P5875 | ResearchGate publication ID | 11260932 |
| P2093 | author name string | Ching-Wan Lam | |
| Juey-Jen Hwang | |||
| Choong-Chin Liew | |||
| George C Tseng | |||
| Victor J Dzau | |||
| Paul D Allen | |||
| Lameh Fananapazir | |||
| P2860 | cites work | Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects | Q39094360 |
| No eczema without keratinocyte death | Q40432123 | ||
| Hypertrophic cardiomyopathy. Clinical spectrum and treatment. | Q40480276 | ||
| Developing a strategy to define the effects of insulin-like growth factor-1 on gene expression profile in cardiomyocytes | Q40700832 | ||
| On genetics of dilated cardiomyopathy and transgenic models: all is not crystal clear in myopathic hearts | Q42738736 | ||
| Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene | Q43686069 | ||
| Glycolysis in heart failure: a 31P-NMR and surface fluorometry study | Q46275312 | ||
| Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice | Q48015924 | ||
| Analysis of gene expression in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. | Q48904070 | ||
| Many roads lead to a broken heart: the genetics of dilated cardiomyopathy | Q24535744 | ||
| Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes | Q24657150 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Quantitative monitoring of gene expression patterns with a complementary DNA microarray | Q27861102 | ||
| Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1 | Q28140811 | ||
| Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy | Q28145069 | ||
| Identification of a gene responsible for familial Wolff-Parkinson-White syndrome | Q28201949 | ||
| Expression and localization of lumican in the ischemic and reperfused rat heart | Q28571856 | ||
| Use of a cDNA microarray to analyse gene expression patterns in human cancer | Q29618814 | ||
| Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags | Q30650615 | ||
| Construction of a human cardiovascular cDNA microarray: portrait of the failing heart | Q30650689 | ||
| DNA microarrays and beyond: completing the journey from tissue to cell | Q30696767 | ||
| Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome | Q32129470 | ||
| A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. | Q32161221 | ||
| Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations | Q33915649 | ||
| A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease | Q33935449 | ||
| The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy | Q33974762 | ||
| The Molecular Biology Database Collection: 2002 update | Q34010756 | ||
| Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults | Q34058337 | ||
| Peptide-based targeting of fluorophores to peroxisomes in living cells | Q34123294 | ||
| Cytoplasmic signaling pathways that regulate cardiac hypertrophy | Q34142151 | ||
| Antioxidant function of thioredoxin and glutaredoxin systems | Q34159139 | ||
| Genomics and the pathophysiology of heart failure | Q34221034 | ||
| Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy | Q35801335 | ||
| P433 | issue | 1 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 31-44 | |
| P577 | publication date | 2002-07-12 | |
| P1433 | published in | Physiological Genomics | Q2506446 |
| P1476 | title | Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure | |
| P478 | volume | 10 |
| Q36800993 | 'End-stage' hypertrophic cardiomyopathy: from mystery to model |
| Q24815374 | A comparative study of discriminating human heart failure etiology using gene expression profiles |
| Q31040646 | A comprehensive nonredundant expressed sequence tag collection for the developing Rattus norvegicus heart |
| Q30983627 | A systematic review of large scale and heterogeneous gene array data in heart failure |
| Q41466008 | Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure |
| Q30498939 | Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy |
| Q31043414 | Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data |
| Q36807865 | Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats |
| Q47806965 | Alterations of gene expression in failing myocardium following left ventricular assist device support |
| Q54567679 | Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. |
| Q54509281 | Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study. |
| Q31160132 | Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies |
| Q38826375 | Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers |
| Q50890996 | Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy. |
| Q45205031 | Cardiac gene expression profile in rats with terminal heart failure and cachexia |
| Q35085050 | Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. |
| Q36853955 | Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene |
| Q37408433 | Cardiovascular translational medicine (III). Genomics and proteomics in heart failure research |
| Q57912008 | Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP form |
| Q35732935 | Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function |
| Q35608981 | Clinical applications of DNA microarray analysis. |
| Q54378689 | Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis. |
| Q38295801 | Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses |
| Q24299985 | DAMAGE, a Novel α-Dystrobrevin-associated MAGE Protein in Dystrophin Complexes |
| Q39852231 | Differential Changes in TGF-β/BMP Signaling Pathway in the Right Ventricular Myocardium of Newborns With Hypoplastic Left Heart Syndrome |
| Q42603701 | Differential myocardial gene expression in the development and rescue of murine heart failure |
| Q33211643 | Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays |
| Q36726587 | Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart |
| Q34652525 | Earliest changes in the left ventricular transcriptome postmyocardial infarction |
| Q33900451 | Elevated miR-499 levels blunt the cardiac stress response |
| Q36130579 | Expressed genome molecular signatures of heart failure |
| Q54470952 | Expression of mRNA of apolipoprotein E, apolipoprotein A-IV, and matricellular proteins in the myocardium and intensity of fibroplastic processes during experimental hypercholesterolemia. |
| Q35978591 | Expression profiling of cardiovascular disease |
| Q46534803 | Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy |
| Q33199739 | Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation. |
| Q47284005 | Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes |
| Q36277988 | Gene expression profiling in human cardiovascular disease |
| Q36748452 | Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure |
| Q35758712 | Gene expression profiling: from microarrays to medicine. |
| Q79895265 | Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium |
| Q38125765 | Genetic biomarkers in hypertrophic cardiomyopathy. |
| Q38521114 | Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats |
| Q39050554 | Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders |
| Q35005805 | Genomic analysis of circulating cells: a window into atherosclerosis |
| Q51887932 | Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies. |
| Q34314129 | Genomics, proteomics and bioinformatics of human heart failure |
| Q38521995 | Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. |
| Q35822160 | Glycoproteins identified from heart failure and treatment models |
| Q42713273 | Heart failure-associated changes in RNA splicing of sarcomere genes |
| Q83667474 | Heart failure: advances through genomics |
| Q33321366 | Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences |
| Q36748674 | Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy |
| Q33454995 | Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease |
| Q34571329 | Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. |
| Q34179181 | Increased myocardial expression of angiopoietin-2 in patients undergoing urgent surgical revascularization for acute coronary syndromes |
| Q30666168 | Insights from the clustering of microarray data associated with the heart disease |
| Q57395343 | La genómica y la proteómica en la investigación de la insuficiencia cardiaca |
| Q38088851 | Large-scale studies to identify biomarkers for heart disease: a role for proteomics? |
| Q34124934 | Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy |
| Q53116892 | Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. |
| Q95653893 | Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19 |
| Q36524657 | Metabolism of arachidonic acid by the cytochrome P450 enzyme in patients with chronic Keshan disease and dilated cardiomyopathy |
| Q38101386 | Microarray analysis in cardiac arrhythmias: a new perspective? |
| Q35128069 | Microarray analysis: a novel research tool for cardiovascular scientists and physicians. |
| Q37054218 | Mitochondrial centrality in heart failure |
| Q36660421 | Mitochondrial-nuclear cross-talk in the aging and failing heart |
| Q34700605 | Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene |
| Q35936390 | Molecular genetics and genomics of heart failure |
| Q36473503 | Molecular mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin cardiovascular embryotoxicity |
| Q40377138 | Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy |
| Q38037357 | Molecular signatures and the study of gene expression profiles in inflammatory heart diseases |
| Q38704770 | Novel regulators of cardiac inflammation: Matricellular proteins expand their repertoire |
| Q37189947 | PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart |
| Q37075424 | Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure |
| Q38519784 | Potential markers of tongue tumor progression selected by cDNA microarray. |
| Q36898747 | Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine |
| Q42972445 | Primary endothelial damage is the mechanism of cardiotoxicity of tubulin-binding drugs |
| Q34073964 | Protein quality control in protection against systolic overload cardiomyopathy: the long term role of small heat shock proteins |
| Q44201847 | Proteomic remodeling of proteasome in right heart failure |
| Q33484098 | Purification of cardiac myocytes from human heart biopsies for gene expression analysis |
| Q34172616 | Recent progress in histochemistry and cell biology |
| Q36100558 | Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure |
| Q91885085 | Reduced hybrid/complex N-glycosylation disrupts cardiac electrical signaling and calcium handling in a model of dilated cardiomyopathy |
| Q57124944 | Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy |
| Q34497218 | Regulation of neuronal type genes in congestive heart failure rats |
| Q34680942 | Role of the ubiquitin-proteasome system in cardiac dysfunction of adipose triglyceride lipase-deficient mice |
| Q37258938 | Serial gene expression profiling in the intact human heart |
| Q34808395 | Sex- and age-dependent human transcriptome variability: implications for chronic heart failure |
| Q34152309 | The effect of disease on human cardiac protein expression profiles in paired samples from right and left ventricles. |
| Q37788836 | The role of the proteasome in heart disease |
| Q36773687 | The use of transcriptomic biomarkers for personalized medicine |
| Q28292062 | Thick filament proteins and performance in human heart failure |
| Q43024151 | Transcriptional changes associated with recovery from heart failure in the SHR. |
| Q52112465 | Transcriptomal analysis of failing and nonfailing human hearts. |
| Q59136280 | Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure |
| Q34652219 | Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling |
| Q82227890 | Transition from compensated hypertrophy to systolic heart failure in the spontaneously hypertensive rat: Structure, function, and transcript analysis |
| Q37216612 | Uncoupling proteins in heart failure |
Search more.